businesspress24.com - Trxade Group CEO to Present at the 2015 LD Micro Invitational Conference in Los Angeles on June 2nd
 

Trxade Group CEO to Present at the 2015 LD Micro Invitational Conference in Los Angeles on June 2nd

ID: 1361965

(firmenpresse) - TAMPA, FL -- (Marketwired) -- 05/28/15 -- Trxade Group, Inc. (OTCQB: TRXD), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today that Suren Ajjarapu, Chairman and CEO, is scheduled to present at the upcoming LD Micro Invitational Conference on Tuesday, June 2nd, 2015. The 2015 LD Micro Invitational Conference will be held in Los Angeles at the Luxe Sunset Boulevard Hotel.

Trxade Group''s presentation is scheduled to begin at 12:00PM ET for additional information about Trxade Group, or to view the company''s corporate presentation, please visit .

The LD micro Invitational Conference is a showcase for public companies with less than $500 million in market capitalization. For more information or to register, please visit the conference website at



LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Main Event in December. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit .



Headquartered in Tampa, Florida, Trxade Group, Inc. is a web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. Founded in 2010, Trxade Group currently operates the trading platform with 3500 registered members. Trxade Group also distribute directly private label pharmaceuticals thru their 100% subsidiary Westminster Pharmaceuticals to these registered members. For additional information please visit us at



The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.





You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements.

Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. Except as may be required by applicable law, we assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The company undertakes no duty to update forward-looking statements.



(800) 261-0281


(941) 228-0162


Mark Bernhard
(415) 332-7200 Ext. 222


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Boston Therapeutics & University at Buffalo''s Translational Pharmacology Research Core Initiates BTI-320 Clinical Trials Alliance in Buffalo, NY and NYC''s Chinatown
IsoRay''s Intra-Cranial Brachytherapy Brain Cancer Treatments Utilizing Cesium-131 Were Presented at the Brain Tumor Biotech Summit 2015
Bereitgestellt von Benutzer: Marketwired
Datum: 28.05.2015 - 07:00 Uhr
Sprache: Deutsch
News-ID 1361965
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

TAMPA, FL


Phone:

Kategorie:

Hospitals, Facilities and Providers


Anmerkungen:


Diese Pressemitteilung wurde bisher 125 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Trxade Group CEO to Present at the 2015 LD Micro Invitational Conference in Los Angeles on June 2nd
"
steht unter der journalistisch-redaktionellen Verantwortung von

Trxade Group, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Trxade Group, Inc.



 

Who is online

All members: 10 563
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 94


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.